These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31210677)

  • 21. Associations between essential medicines and health outcomes for cardiovascular disease.
    Steiner L; Fraser S; Maraj D; Persaud N
    BMC Cardiovasc Disord; 2021 Mar; 21(1):151. PubMed ID: 33765933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.
    Liu D; Cheng J; Zhang LL; Li YP; Zeng LN; Zhang C; Gui G
    J Evid Based Med; 2017 Nov; 10(4):271-280. PubMed ID: 28276634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys.
    Holloway KA; Henry D
    PLoS Med; 2014 Sep; 11(9):e1001724. PubMed ID: 25226527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential diabetes medicines and health outcomes in 127 countries.
    Budhram D; Benipal S; Bilimoria K; Maraj D; Wang R; Persaud N
    Diabetes Obes Metab; 2021 May; 23(5):1121-1128. PubMed ID: 33417268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports.
    Mahmić-Kaknjo M; Marušić A
    Eur J Clin Pharmacol; 2015 Jul; 71(7):825-33. PubMed ID: 25956715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Access to Cytotoxic Medicines by Children With Cancer: A Focus on Low and Middle Income Countries.
    Barr R; Robertson J
    Pediatr Blood Cancer; 2016 Feb; 63(2):287-91. PubMed ID: 26375626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applying the essential medicines concept to US preferred drug lists.
    Millar TP; Wong S; Odierna DH; Bero LA
    Am J Public Health; 2011 Aug; 101(8):1444-8. PubMed ID: 21680927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
    Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
    Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential psychiatric medicines: wrong selection, high consumption and social problems.
    Fulone I; Barberato-Filho S; dos Santos MF; Rossi Cde L; Guyatt G; Lopes LC
    BMC Public Health; 2016 Jan; 16():52. PubMed ID: 26792369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monographs for medicines on WHO's Model List of Essential Medicines.
    Roth L; Adler M; Jain T; Bempong D
    Bull World Health Organ; 2018 Jun; 96(6):378-385. PubMed ID: 29904220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.
    Todesco B; Ostuzzi G; Barbui C
    Epidemiol Psychiatr Sci; 2022 Apr; 31():e22. PubMed ID: 35438063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innovation and the WHO's essential medicines list: giving credit where credit is due.
    Wertheimer AI; Santella TM
    Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562
    [No Abstract]   [Full Text] [Related]  

  • 34. Essential medicines availability is still suboptimal in many countries: a scoping review.
    Mahmić-Kaknjo M; Jeličić-Kadić A; Utrobičić A; Chan K; Bero L; Marušić A
    J Clin Epidemiol; 2018 Jun; 98():41-52. PubMed ID: 29452222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Priority medicines for maternal and child health: a global survey of national essential medicines lists.
    Hill S; Yang A; Bero L
    PLoS One; 2012; 7(5):e38055. PubMed ID: 22675435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of Blood, Blood Components, and Blood Products as Essential Medicines in 105 Low- and Middle-Income Countries.
    Samukange WT; Gardarsdottir H; Leufkens HGM; Mantel-Teeuwisse AK
    Transfus Med Rev; 2020 Apr; 34(2):94-100. PubMed ID: 31761652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Price discrimination in essential medicines: evidence from International Drug Price Indicator Guide data.
    Hanlon M; Zhang R
    Int Health; 2013 Mar; 5(1):58-63. PubMed ID: 24029847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey.
    Denburg AE; Fundytus A; Khan MS; Howard SC; Antillon-Klussmann F; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
    JCO Glob Oncol; 2022 Jun; 8():e2200034. PubMed ID: 35749676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method for understanding generic procurement of HIV medicines by developing countries with patent protection.
    Beall RF; Attaran A
    Soc Sci Med; 2017 Jul; 185():118-126. PubMed ID: 28578209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Access and use of WHO essential medicines in Italy.
    Petrella A; Fortinguerra F; Cangini A; Pierantozzi A; Trotta F
    Front Public Health; 2023; 11():1211208. PubMed ID: 37881343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.